Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Targeted OMA1 therapies for cancer.

Alavi MV.

Int J Cancer. 2019 Nov 1;145(9):2330-2341. doi: 10.1002/ijc.32177. Epub 2019 Feb 21. Review.

PMID:
30714136
2.

Long-term photoreceptor rescue in two rodent models of retinitis pigmentosa by adeno-associated virus delivery of Stanniocalcin-1.

Roddy GW, Yasumura D, Matthes MT, Alavi MV, Boye SL, Rosa RH Jr, Fautsch MP, Hauswirth WW, LaVail MM.

Exp Eye Res. 2017 Dec;165:175-181. doi: 10.1016/j.exer.2017.09.011. Epub 2017 Sep 30.

3.

Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis.

Ward ME, Chen R, Huang HY, Ludwig C, Telpoukhovskaia M, Taubes A, Boudin H, Minami SS, Reichert M, Albrecht P, Gelfand JM, Cruz-Herranz A, Cordano C, Alavi MV, Leslie S, Seeley WW, Miller BL, Bigio E, Mesulam MM, Bogyo MS, Mackenzie IR, Staropoli JF, Cotman SL, Huang EJ, Gan L, Green AJ.

Sci Transl Med. 2017 Apr 12;9(385). pii: eaah5642. doi: 10.1126/scitranslmed.aah5642.

4.

Col4a1 mutations cause progressive retinal neovascular defects and retinopathy.

Alavi MV, Mao M, Pawlikowski BT, Kvezereli M, Duncan JL, Libby RT, John SW, Gould DB.

Sci Rep. 2016 Jan 27;6:18602. doi: 10.1038/srep18602.

5.

Type IV Collagens and Basement Membrane Diseases: Cell Biology and Pathogenic Mechanisms.

Mao M, Alavi MV, Labelle-Dumais C, Gould DB.

Curr Top Membr. 2015;76:61-116. doi: 10.1016/bs.ctm.2015.09.002. Epub 2015 Oct 20. Review.

PMID:
26610912
6.

Strain-Dependent Anterior Segment Dysgenesis and Progression to Glaucoma in Col4a1 Mutant Mice.

Mao M, Smith RS, Alavi MV, Marchant JK, Cosma M, Libby RT, John SW, Gould DB.

Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6823-31. doi: 10.1167/iovs.15-17527.

7.

In Vivo Visualization of Endoplasmic Reticulum Stress in the Retina Using the ERAI Reporter Mouse.

Alavi MV, Chiang WC, Kroeger H, Yasumura D, Matthes MT, Iwawaki T, LaVail MM, Gould DB, Lin JH.

Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6961-70. doi: 10.1167/iovs.15-16969.

8.

Aging and Vision.

Alavi MV.

Adv Exp Med Biol. 2016;854:393-9. doi: 10.1007/978-3-319-17121-0_52.

PMID:
26427437
9.

Allosteric inhibition of the IRE1α RNase preserves cell viability and function during endoplasmic reticulum stress.

Ghosh R, Wang L, Wang ES, Perera BG, Igbaria A, Morita S, Prado K, Thamsen M, Caswell D, Macias H, Weiberth KF, Gliedt MJ, Alavi MV, Hari SB, Mitra AK, Bhhatarai B, Schürer SC, Snapp EL, Gould DB, German MS, Backes BJ, Maly DJ, Oakes SA, Papa FR.

Cell. 2014 Jul 31;158(3):534-48. doi: 10.1016/j.cell.2014.07.002. Epub 2014 Jul 10.

10.

Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics.

Alavi MV, Fuhrmann N.

Mol Neurodegener. 2013 Sep 25;8:32. doi: 10.1186/1750-1326-8-32. Review.

11.

Altered skeletal muscle mitochondrial biogenesis but improved endurance capacity in trained OPA1-deficient mice.

Caffin F, Prola A, Piquereau J, Novotova M, David DJ, Garnier A, Fortin D, Alavi MV, Veksler V, Ventura-Clapier R, Joubert F.

J Physiol. 2013 Dec 1;591(23):6017-37. doi: 10.1113/jphysiol.2013.263079. Epub 2013 Sep 16.

12.

Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload.

Piquereau J, Caffin F, Novotova M, Prola A, Garnier A, Mateo P, Fortin D, Huynh le H, Nicolas V, Alavi MV, Brenner C, Ventura-Clapier R, Veksler V, Joubert F.

Cardiovasc Res. 2012 Jun 1;94(3):408-17. doi: 10.1093/cvr/cvs117. Epub 2012 Mar 8.

13.

A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics.

Nguyen D, Alavi MV, Kim KY, Kang T, Scott RT, Noh YH, Lindsey JD, Wissinger B, Ellisman MH, Weinreb RN, Perkins GA, Ju WK.

Cell Death Dis. 2011 Dec 8;2:e240. doi: 10.1038/cddis.2011.117.

14.

Excessive HDAC activation is critical for neurodegeneration in the rd1 mouse.

Sancho-Pelluz J, Alavi MV, Sahaboglu A, Kustermann S, Farinelli P, Azadi S, van Veen T, Romero FJ, Paquet-Durand F, Ekström P.

Cell Death Dis. 2010;1:e24. doi: 10.1038/cddis.2010.4.

15.

A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16.

Carelli V, Schimpf S, Fuhrmann N, Valentino ML, Zanna C, Iommarini L, Papke M, Schaich S, Tippmann S, Baumann B, Barboni P, Longanesi L, Rugolo M, Ghelli A, Alavi MV, Youle RJ, Bucchi L, Carroccia R, Giannoccaro MP, Tonon C, Lodi R, Cenacchi G, Montagna P, Liguori R, Wissinger B.

Hum Mol Genet. 2011 May 15;20(10):1893-905. doi: 10.1093/hmg/ddr071. Epub 2011 Feb 24.

PMID:
21349918
16.

Solving a 50 year mystery of a missing OPA1 mutation: more insights from the first family diagnosed with autosomal dominant optic atrophy.

Fuhrmann N, Schimpf S, Kamenisch Y, Leo-Kottler B, Alexander C, Auburger G, Zrenner E, Wissinger B, Alavi MV.

Mol Neurodegener. 2010 Jun 14;5:25. doi: 10.1186/1750-1326-5-25.

17.

Electrophysiological and histologic assessment of retinal ganglion cell fate in a mouse model for OPA1-associated autosomal dominant optic atrophy.

Heiduschka P, Schnichels S, Fuhrmann N, Hofmeister S, Schraermeyer U, Wissinger B, Alavi MV.

Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1424-31. doi: 10.1167/iovs.09-3606. Epub 2009 Oct 15.

PMID:
19834041
18.

Subtle neurological and metabolic abnormalities in an Opa1 mouse model of autosomal dominant optic atrophy.

Alavi MV, Fuhrmann N, Nguyen HP, Yu-Wai-Man P, Heiduschka P, Chinnery PF, Wissinger B.

Exp Neurol. 2009 Dec;220(2):404-9. doi: 10.1016/j.expneurol.2009.09.026. Epub 2009 Oct 6.

PMID:
19815013
19.

Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy.

Fuhrmann N, Alavi MV, Bitoun P, Woernle S, Auburger G, Leo-Kottler B, Yu-Wai-Man P, Chinnery P, Wissinger B.

J Med Genet. 2009 Feb;46(2):136-44. doi: 10.1136/jmg.2008.062570.

PMID:
19181907
20.

Identification of genes that are linked with optineurin expression using a combined RNAi--microarray approach.

Weisschuh N, Alavi MV, Bonin M, Wissinger B.

Exp Eye Res. 2007 Oct;85(4):450-61. Epub 2007 Jun 27.

PMID:
17663987
21.

A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy.

Alavi MV, Bette S, Schimpf S, Schuettauf F, Schraermeyer U, Wehrl HF, Ruttiger L, Beck SC, Tonagel F, Pichler BJ, Knipper M, Peters T, Laufs J, Wissinger B.

Brain. 2007 Apr;130(Pt 4):1029-42. Epub 2007 Feb 21.

PMID:
17314202

Supplemental Content

Loading ...
Support Center